April 16 – 20, 2016, Ernest N. Morial Convention Center, New Orleans, LA
The American Association for Cancer Research (AACR) Annual Meeting is quickly approaching. See below for links to major sessions featuring pancreatic cancer-related presentations. Many of the session chairs and speakers are advisors or grantees of the Pancreatic Cancer Action Network. Please click on the session name for details.
Sessions organized by the Pancreatic Cancer Action Network are designated by an asterisk.
To access AACR’s itinerary planner and locate other relevant scientific and poster presentations, click here.
SATURDAY, APRIL 16
AACR Runners for Research 5K Run/Walk
Team Pancreatic Cancer Action Network
Start/Finish Line Location: World Trade Center (Canal/Convention Center Boulevard)
SUNDAY, APRIL 17
Funding Opportunities from the Recalcitrant Cancer Research Act of 2012
1 – 2 p.m., Room 352, Morial Convention Center
*Meet the Research Icon
Meet the Pancreatic Cancer Research Icon: Frank McCormick, PhD, FRS, DSc (Hon)
2:30 – 3:30 p.m., AACRcentral Amphitheater
This interactive and informal session is an opportunity to meet and speak with world-renowned pancreatic cancer researcher Dr. Frank McCormick and learn how he charted a successful career and his efforts developing therapies against Ras-driven cancers, including pancreatic cancer. This session will be mediated by Lynn Matrisian, PhD, MBA, vice president of scientific and medical affairs at the Pancreatic Cancer Action Network.
Poster Session: Genomic Analysis of Cancers
Molecular profiling of pancreatic cancer patients from a wide geographical distribution across the US
1 – 5 p.m., Section 4, Poster Board Number 7
The NCI RAS Initiative at the Frederick National Laboratory for Cancer Research
3:45 – 5:15 p.m., Room 254, Morial Convention Center
MONDAY, APRIL 18
Converting Pancreatic Cancer into an Immunologic Disease
7 – 8 a.m., Room 265, Morial Convention Center
Drugging the “Undruggable” RAS Oncogene: Reality or Reality Distortion?
7 – 8 a.m., Room 243, Morial Convention Center
Scientist-Survivor Program, featuring Pancreatic Cancer Action Network volunteer Maurice Bason and Yoshi Majima of PanCAN Japan
8 – 10 a.m.
Recent Advances in Organ Site Research Session
Targeting Stromal Fibroblasts in Pancreatic Cancer: Controversy or Consensus?
10:30 a.m. – 12:15 p.m., Room 293, Morial Convention Center
Career Paths in Pancreatic Cancer Research
1:15 – 2:15 p.m., AACRcentral Amphitheater
This session, which focuses on career paths in the field of pancreatic cancer in both academia and industry, will be co-led by Dr. Victoria G. Manax, Executive Director, US Medical Affairs, for Celgene Corporation, and Dr. Kenneth P. Olive, Assistant Professor of Medicine and Pathology at Columbia University Medical Center. This informal and interactive session will provide the opportunity to interact with both a leader in the pharmaceutical industry and a highly successful academic pancreatic cancer investigator, and it also will focus on basic, translational and clinical research paths in the pancreatic cancer research field. This session will be mediated by Lynn Matrisian, PhD, MBA, vice president of scientific and medical affairs at the Pancreatic Cancer Action Network.
SU2C Scientific Session: Translating Advances in Immunotherapy to Patient Benefit
Clinical prospect of targeting immune vulnerabilities in pancreatic cancer
1:21 – 1:44 p.m., Room 243, Morial Convention Center
TUESDAY, APRIL 19
Pancreatic Cancer Action Network-AACR Research Grants Presentation Session
10:30 a.m. – 12:30 p.m., Grand Salon A, Hilton New Orleans Riverside
This session aims to stimulate opportunities for collaboration between Pancreatic Cancer Action Network – AACR grantees and others in the pancreatic cancer research field. Junior and senior investigators will deliver presentations highlighting progress on their funded research projects, followed by moderated question and answer sessions.
Scientist – Survivor Program, featuring Pancreatic Cancer Action Network volunteer Maurice Bason and Yoshi Majima of PanCAN Japan
1 – 5 p.m.